Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The use of 5-azacytidine to establish constitutive interleukin 2-producing clones of the EL4 thymoma.

Literature DB >> 6202793

The use of 5-azacytidine to establish constitutive interleukin 2-producing clones of the EL4 thymoma.

Z K Ballas.

Abstract

Entities: Chemical Disease Gene

Mesh：

Substances：
Interleukin-2
Azacitidine

Year: 1984 PMID： 6202793

Source DB: PubMed Journal: J Immunol ISSN： 0022-1767 Impact factor: 5.422

Keyword Cloud
Cited

× No keyword cloud information.

19 in total

1. Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects.

Authors: Grégory Ehx; Gilles Fransolet; Laurence de Leval; Stéphanie D'Hondt; Sophie Lucas; Muriel Hannon; Loïc Delens; Sophie Dubois; Pierre Drion; Yves Beguin; Stéphanie Humblet-Baron; Frédéric Baron
Journal: Oncoimmunology Date: 2017-04-12 Impact factor: 8.110

Review 2. Epigenetic control of T-helper-cell differentiation.

Authors: Christopher B Wilson; Emily Rowell; Masayuki Sekimata
Journal: Nat Rev Immunol Date: 2009-02 Impact factor: 53.106

3. In-vivo treatment with 5-azacytidine causes degeneration of central lymphatic organs and induces autoimmune disease in the chicken.

Authors: K Schauenstein; A Csordas; G Krömer; H Dietrich; G Wick
Journal: Int J Exp Pathol Date: 1991-06 Impact factor: 1.925

4. Dynamic demethylation of the IL2RA promoter during in vitro CD4+ T cell activation in association with IL2RA expression.

Authors: Marie-Pierre Belot; Anne-Laure Castell; Sophie Le Fur; Pierre Bougnères
Journal: Epigenetics Date: 2018-08-10 Impact factor: 4.528

Review 5. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity.

Authors: Yuka Kanno; Golnaz Vahedi; Kiyoshi Hirahara; Kentner Singleton; John J O'Shea
Journal: Annu Rev Immunol Date: 2012-01-06 Impact factor: 28.527

10. Clonal analysis of the malignant properties of B16 melanoma cells treated with the DNA hypomethylating agent 5-azacytidine.

Authors: D L Trainer; T Kline; G Hensler; R Greig; G Poste
Journal: Clin Exp Metastasis Date: 1988 May-Jun Impact factor: 5.150

The use of 5-azacytidine to establish constitutive interleukin 2-producing clones of the EL4 thymoma.

1. Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects.

Review 2. Epigenetic control of T-helper-cell differentiation.

3. In-vivo treatment with 5-azacytidine causes degeneration of central lymphatic organs and induces autoimmune disease in the chicken.

4. Dynamic demethylation of the IL2RA promoter during in vitro CD4+ T cell activation in association with IL2RA expression.

Review 5. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity.

6. Defining CD4 T cell memory by the epigenetic landscape of CpG DNA methylation.

7. Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome.

Review 8. Epigenetics: deciphering how environmental factors may modify autoimmune type 1 diabetes.

Review 9. Engineering lymphocyte subsets: tools, trials and tribulations.

10. Clonal analysis of the malignant properties of B16 melanoma cells treated with the DNA hypomethylating agent 5-azacytidine.